December 01, 2008
|Media contact: Katie Vloet
Childhood vaccines cause financial burden to health care providers
Prices, reimbursements of vaccines vary widely, U-M studies find
ANN ARBOR, Mich. — The costs that health care providers are charged and reimbursed for childhood vaccines vary widely, and the high cost of some immunizations is leading to significant financial strain for some physicians, according to a pair of new studies from the University of Michigan Health System.
The findings suggest that many physicians appear to be paying too much and receiving too little reimbursement, but they can use this new data to help improve both areas, the researchers say.
With vaccines for children enrolled in Medicaid funded by the public sector through the federal Vaccines for Children Program, prices are negotiated annually with vaccine manufacturers by the Centers for Disease Control and Prevention. But the data from the new studies support the belief that costs and reimbursements are widely variable in private practices.
“Until now, nobody knew what anyone was paying,” Freed notes. “This information will change the way in which physicians negotiate prices.” The studies appear in the December issue of the journal Pediatrics
The studies found that the price-per-dose of one brand of hepatitis B vaccine, for example, ranged from $4.26 to $13.06 at different medical practices. Reimbursements of the MMR (measles, mumps and rubella) vaccine ranged from $16.77 to $59.02. Many physicians in the survey expressed dissatisfaction with the price and reimbursement levels of vaccines.
The good news for physicians is that they can join purchasing cooperatives in which they band together to get a better rate as a group than they would as individuals, Freed says. Additionally, physicians who are paying more for vaccines can follow the lead of their peers who have negotiated prompt-pay discounts and volume discounts.
While few physicians in the survey indicated that they had considered no longer providing all vaccines to privately insured children (11 percent overall; 5 percent of pediatricians and 21 percent of family physicians), about half of them reported that they had delayed the purchase of some vaccines for financial reasons and experienced a decline in profit margins from immunizations. While the study did not specifically look at the effect on costs to patients, Freed notes that most of the vaccines are not associated with out-of-pocket expenses for insured families or for those on Medicaid.
By the numbers: Researchers mailed a survey to 1,280 U.S. pediatricians and family physicians engaged in direct patient care. Of the pediatricians, 70 percent responded, along with 60 percent of family physicians. The study of costs and reimbursements included data from 76 practices.
Authors: In addition to Freed, authors of both papers were Sarah J. Clark, MPH, and Anne E. Cowan of the Child Health Evaluation and Research Unit. Sashi Gregory, MPH, also was an author of the reimbursement study.
Funding: The Centers for Disease Control and Prevention.
Reference: Pediatrics, Vol. 122, Number 6, December 2008, “Variation in Provider Vaccine Purchase Prices and Payer Reimbursement” and “Primary Care Physician Perspectives on Reimbursement for Childhood Immunizations.”
# # #